Bayer Pharmaceuticals has recently shifted its focus even more to external innovation, resulting in a growing number of alliances and a redeployment of internal staff. This coupled with pursuing new types of partners and more complex alliance networks necessitates the need for both organizational culture change and an increase in alliance capability.
Many organizations have experienced or will eventually go through similar strategic changes leading to a stronger focus on external innovation, or externalization in general. Learn how Bayer is making this transition and the crucial role alliance management can play during the process including:
Christoph Huwe, CSAP, PhD
Strategic Alliance Manager Therapeutics
Bayer AG Pharmaceuticals
Christoph has more than 20 years of experience in the pharmaceutical industry in different roles at Bayer (Germany), Berlex Biosciences (USA) and Schering AG (Germany).
He has been responsible for alliances and consortia in Europe, the US and China for more than 10 years, covering various therapeutic areas.
He is also a founding member of Bayer's Alliance Community Excellence team focussing on alliance management capability development, and has served as member of the Pharma Industry Benchmarking Forum and the EFPIA Industry Liaison Group.
Michael Kennedy, PhD
Director Alliance Management, Business Development & Licensing
Michael Kennedy is an experienced alliance management professional with 20 plus years' experience in the pharmaceutical industry embracing local, regional and global roles. He joined the Bayer AG BD&L / Alliance Management Team in 2012. Prior to that Michael was Vice President, Head of Alliance Management at Mylan Pharmaceuticals. Before that he ran Business Operations for Pfizer Animal Health. In various leadership roles Michael has led efforts to build out organizational partnering capability and develop partnering strategies. As an alliance manager he has been instrumental in identifying and pursuing strategic partnerships and business opportunities to expand markets, generate new sources of revenue and maximize the value of the alliances he has managed.